Stock AMGN AMGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Amgen Inc.

Equities

AMGN

US0311621009

Real-time Estimate Cboe BZX
Other stock markets
 02:47:35 2024-04-19 pm EDT 		5-day change 1st Jan Change
267.4 USD +1.78% Intraday chart for Amgen Inc. +0.05% -7.15%
Apr. 17 UBS Adjusts Amgen's Price Target to $284 From $314, Maintains Neutral Rating MT
Apr. 16 Amgen Plans for Phase 3 Trial of Tezepelumab for Lung Disease MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Amgen : First Cancer Diagnosis Led to a Dark Place—Aiding Another Helped Lift Him Out of It
PU
AMGEN TO PRESENT TEZSPIRE PHASE 2A COPD DATA AT ATS 2024
AQ
UBS Adjusts Amgen's Price Target to $284 From $314, Maintains Neutral Rating
MT
Amgen Plans for Phase 3 Trial of Tezepelumab for Lung Disease
MT
Navigating the Landscape of Precision Medicine in Gastric Cancer: FGFR2b Protein Overexpression as an Emerging Biomarker
PU
TD Cowen Cuts Price Target on Amgen to $360 From $370, Buy Rating Kept
MT
Goldman Sachs Adjusts Amgen Price Target to $359 From $361, Maintains Buy Rating
MT
Neumora's early-stage schizophrenia drug study put on hold
RE
BMO Lowers Price Target on Amgen to $336 From $343
MT
Amgen : CEO Bob Bradway's 2023 Letter to Shareholders
PU
Amgen : Chairman and CEO Letter and Amgen Inc. 2023 Annual Report
PU
Morgan Stanley Raises 2024, 2025 EPS Estimates for Regeneron Pharmaceuticals, Amgen
MT
Morgan Stanley Cuts Price Target on Amgen to $271 From $278, Keeps Equalweight Rating
MT
Boehringer to lay off salespeople as Humira biosimilar sales lag
RE
Boehringer to lay off salespeople as Humira biosimilar sales lag
RE
Amgen : How the LATTICE™ Consortium Is Igniting Action and Innovation in Cardiovascular Care
PU
US takes next step in Medicare drug price negotiations with pharma companies
RE
Updates On Aflibercept BPCIA Litigation
AQ
Amgen : Jean-Charles Soria Elected to American Association for Cancer Research Board of Directors
PU
FDA Approves Sandoz Denosumab Biosimilars
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AMGN Stock
  4. News Amgen Inc.